200 Mg Gemcitabine Injection IP

Get a Price/Quote

MOQ : 1 Vial

200 Mg Gemcitabine Injection IP Specification

Salt Composition
Gemcitabine Hydrochloride 200 mg

Indication
For the treatment of various cancers, including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer

Dosage Form
Injection (Lyophilized Powder for Reconstitution)

Feature
Lyophilized; Sterile; For single use only

Ingredients
Gemcitabine Hydrochloride, Excipients

Application

Ph Level
Not specified (typically neutral upon reconstitution)

Physical Color/Texture
White to off-white Lyophilized Powder

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light. Keep out of reach of children.

Shelf Life
24 months from date of manufacture

Cytotoxic Handling
Handle with care; use gloves and safety precautions

Pack Size
Single vial containing 200 mg Gemcitabine

Packaging Type
Glass vial with flip-off seal

Reconstitution
To be reconstituted with 0.9% Sodium Chloride Injection

Market Authorization
Prescription only (Rx)

USP/Pharmacopoeia Standard
IP (Indian Pharmacopoeia)

Formulation
Preservative-free formulation

Warnings
For hospital use only; to be administered by healthcare professionals

Route of Administration
Intravenous

About 200 Mg Gemcitabine Injection IP

Experience the invincible efficacy of 200 Mg Gemcitabine Injection IP, an exclusive and top-rated chemotherapeutic solution lauded for its ephemeral yet powerful impact on cancer cell inhibition. Containing ace Gemcitabine Hydrochloride, this preservative-free formulation is provided in a remarked, single-use glass vial with a robust flip-off seal. Precisely developed for intravenous use after reconstitution with 0.9% Sodium Chloride Injection, it strictly adheres to IP standards. Designed for hospital administration by professionals, it delivers remarkable results for diverse cancers including NSCLC, pancreatic, breast, ovarian, and bladder cancers. Handle with utmost care due to cytotoxicity.

Comprehensive Cancer Treatment with Superior Features

200 Mg Gemcitabine Injection IP stands out in oncology for its extensive area of application across various cancers. This lyophilized, sterile, and preservative-free formulation ensures single-use safety and maximum potency. Its primary competitive advantage lies in ace-quality adherence to IP standards and controlled hospital dispensation, making it a remarked choice for cancer treatment. Offered in easy-to-reconstitute vials, it provides exceptional reliability and effectiveness where it's needed most.

Reliable Dispatch & Export-Oriented Packaging

We cater to the global export market, ensuring swift and secure dispatched delivery of 200 Mg Gemcitabine Injection IP. Each vial is carefully packed in a glass container with a flip-off seal, suitable for long-distance transport. Shipments depart from major Indian FOB ports, and every exchange is supported with robust documentation. Packaging details and dispatch timelines are tailored per export requirements, guaranteeing product integrity throughout the supply chain.

FAQ's of 200 Mg Gemcitabine Injection IP:

Q: How should 200 Mg Gemcitabine Injection IP be reconstituted and administered?

A: To reconstitute, use 0.9% Sodium Chloride Injection as specified. The solution must be administered intravenously by qualified healthcare professionals, following hospital protocols and cytotoxic handling guidelines.

Q: What are the primary indications for Gemcitabine 200 Mg Injection IP?

A: This injection is indicated for the treatment of various cancers, including non-small cell lung, pancreatic, breast, ovarian, and bladder cancers, under healthcare supervision.

Q: When should this product be used and by whom?

A: Gemcitabine Injection IP is intended exclusively for hospital use and should only be administered by medical professionals to patients who require it as per oncologist guidance.

Q: Where should the vials be stored before use?

A: Store the vials below 25C, away from direct light, and always keep them out of reach of children to maintain product efficacy and safety until use.

Q: What safety precautions are necessary when handling Gemcitabine Injection?

A: As a cytotoxic agent, handle this drug with gloves and observe strict safety protocols to prevent exposure. Only trained personnel should prepare and administer the injection.

Q: How does the single-use, preservative-free design benefit patients?

A: The single-use, preservative-free and lyophilized formulation minimizes contamination risk and ensures each dose retains peak potency, offering patients optimal therapeutic outcomes with every administration.

Tell us about your requirement